# Wegovy and Ozempic as Once-Monthly Injections ## Key Points: – Wegovy and Ozempic, medications used to aid weight loss, may potentially evolve into once-monthly injections. – The FDA has approved Wegovy for chronic weight management, with patients experiencing an average weight loss of 17%. – Ozempic has shown promising results in clinical trials, with significant weight loss among participants. – By transitioning to once-monthly injections, these medications could improve convenience and adherence for individuals seeking to manage their weight effectively. ### According to the Bennington Banner, the administration of Wegovy and Ozempic may undergo a notable transformation in the future. These medications, designed to support weight loss efforts, hold the potential to change from their current dosing schedules to once-monthly injections. The FDA has already given its stamp of approval to Wegovy for chronic weight management, citing an average weight loss of 17% among patients who have used it. Hot Take: The evolution of Wegovy and Ozempic into once-monthly injections could revolutionize the weight loss journey for many individuals. By offering a more convenient dosing option, patients may find it easier to adhere to their prescribed regimens, thereby potentially enhancing the effectiveness of these medications. If you’re considering weight management options and want to learn more about how telehealth services can support you in states such as Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, New York, South Carolina, Tennessee, Texas, and Virginia, reach out to Mindful Evolution for personalized guidance. Weight Loss Disclaimer: It is essential to consult with a healthcare provider before starting any weight loss medication or program. Individual results may vary, and telehealth services offered by Mindful Evolution are available in select states only: AL, AR, FL, GA, LA, MS, NC, NY, SC, TN, TX, VA.